Trial intelligence / Profile preview

TMS in Relapsing-Remitting Multiple Sclerosis

NCT04062331Phase 2Unknown

Sponsor: Maimónides Institute of Biomedical Research of Córdoba
Start: Oct 2019
Primary completion: Oct 2021

Overview

Phase 2, randomised, single-blind trial (3 arms), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Primary endpoints: Expanded Disability Status Scale at 1 year, Multiple Sclerosis Functional Composite at 1 year and 1 more. Status: unknown.

Beyond the preview

Go deeper on NCT04062331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04062331.